Systemic Embolism and Anticoagulant Prophylaxis in Rheumatic Heart Disease

Szekely, P.

doi:10.1136/bmj.1.5392.1209

Cited by 325Streptococcal Infections and TreatmentsInfective Endocarditis Diagnosis and ManagementVenous Thromboembolism Diagnosis and Management

Systemic Embolism and Anticoagulant Prophylaxis in Rheumatic Heart Disease

Open access

Szekely, P.·1964·BMJ

DOI 10.1136/bmj.1.5392.1209PMC PMC1814317

Open this paper in CoChat — free account Open PDF

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1136/bmj.1.5392.1209

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

AF implies an incremental risk for thromboembolism in patients with mitral valve stenosis.
“while AF implies an incremental risk for thromboembolism in patients with mitral valve stenosis”
From 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS (2016) · cites this paper as [274]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Diseases of the Heart and Circulation
M, M. B. (1957) · Postgraduate Medical Journal · doi:10.1136/pgmj.33.377.147 · Cited by 799 · see citing works
An Appreciation of Mitral Stenosis--I
Wood, P. (1954) · BMJ · doi:10.1136/bmj.1.4870.1051 · Cited by 462 · see citing works
THE COURSE OF MITRAL STENOSIS WITHOUT SURGERY: TEN- AND TWENTY-YEAR PERSPECTIVES
Rowe, J., Bland, E. F., Sprague, H. B., & WHITE, P. D. (1960) · Annals of Internal Medicine · doi:10.7326/0003-4819-52-4-741 · Cited by 281 · see citing works
Systemic arterial embolism in rheumatic heart disease
Daley, R., Mattingly, T. W., Holt, C. L., Bland, E. F., & WHITE, P. D. (1951) · American Heart Journal · doi:10.1016/0002-8703(51)90152-4 · Cited by 245 · see citing works
The Regulation of Human Respiration
CUNNINGHAM, D. J. C., & Landmesser, C. M. (1963) · Anesthesiology · doi:10.1097/00000542-196311000-00043 · Cited by 153 · see citing works
Isolation of a Reovirus from a Case of Burkitt's Lymphoma
Bell, T., Massie, A., ROSS, M. G. R., & Williams, M. (1964) · BMJ · doi:10.1136/bmj.1.5392.1212 · Cited by 79 · see citing works
Systemic Embolism and Left Auricular Thrombosis in Relation to Mitral Valvotomy
Belcher, J., & Somerville, W. (1955) · BMJ · doi:10.1136/bmj.2.4946.1000 · Cited by 78 · see citing works
The Regulation of Human Respiration
Cotes, J. E. (1964) · Occupational and Environmental Medicine · doi:10.1136/oem.21.1.82 · Cited by 78 · see citing works
Arterial embolization in relation to mitral valvuloplasty
Ellis, L. B., & Harken, D. E. (1961) · American Heart Journal · doi:10.1016/0002-8703(61)90369-6 · Cited by 63 · see citing works
PROPHYLAXIS OF RECURRENT EMBOLISM OF INTRACARDIAC ORIGIN
Cosgriff, S. W. (1950) · JAMA · doi:10.1001/jama.1950.02910450010003 · Cited by 59 · see citing works
THE RISKS OF DEFERRING VALVOTOMY IN PATIENTS WITH MODERATE MITRAL STENOSIS
Bannister, R. (1960) · The Lancet · doi:10.1016/s0140-6736(60)91479-3 · Cited by 52 · see citing works
Bronchitis: An International Symposium.
(1962) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.1962.00740050491020 · Cited by 52 · see citing works
Systemic and Pulmonary Emboli before and after Mitral Commissurotomy
Kellogg, F., Liu, C. K., FISHMAN, I. W., & Larson, R. K. (1961) · Circulation · doi:10.1161/01.cir.24.2.263 · Cited by 49 · see citing works
The Results of Anticoagulant Therapy in Norway
OWREN, P. A. (1963) · Archives of Internal Medicine · doi:10.1001/archinte.1963.03620260100018 · Cited by 47 · see citing works
Deterioration after Mitral Valvotomy--I
Lowther, C. P., & Turner, R. (1962) · BMJ · doi:10.1136/bmj.1.5284.1027 · Cited by 46 · see citing works
Ciba Foundation Symposium ‐ Pulmonary Structure and Function
(1962) · Novartis Foundation symposium · doi:10.1002/9780470719282 · Cited by 41 · see citing works
Prevention of Systemic Arterial Embolism in Chronic Rheumatic Heart Disease by Means of Protracted Anticoagulant Therapy
Wood, J. C., & Conn, H. L. (1954) · Circulation · doi:10.1161/01.cir.10.4.517 · Cited by 35 · see citing works
Systemic Arterial Embolism.
BEAN, W. B. (1958) · Archives of Internal Medicine · doi:10.1001/archinte.1958.00260150164026 · Cited by 19 · see citing works
Bronchitis: An International Symposium.
(1965) · Annals of Internal Medicine · doi:10.7326/0003-4819-63-4-732_1 · Cited by 16 · see citing works
Deterioration after mitral valvotomy
Lowther, C. P., & Turner, R. (1963) · American Heart Journal · doi:10.1016/0002-8703(63)90021-8 · Cited by 14 · see citing works
ANTICOAGULANT THERAPY
McMichael, J. (1961) · BMJ · doi:10.1136/bmj.2.5264.1408 · Cited by 13 · see citing works
Some clinical notes on patients with mitral valvular disease who have had mitral valvuloplasty. Part II
Riss, E., & Levine, S. A. (1958) · American Heart Journal · doi:10.1016/0002-8703(58)90192-3 · Cited by 11 · see citing works
Ciba Foundation Symposium on Pulmonary Structure and Function.
(1963) · Annals of Internal Medicine · doi:10.7326/0003-4819-58-4-749_1 · Cited by 9 · see citing works
SYSTEMIC ARTERIAL EMBOLISM
(1957) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1957.tb60177.x · Cited by 8 · see citing works
[Arterial embolism in mitral stenosis and commissurotomy].
RICORDEAU, G., Coblentz, B., & Lenegre, J. (1957) · PubMed · Cited by 4 · see citing works

Flagged first, then by citations

2 of the 27 references couldn’t be matched to a known paper.

Sorted by citations

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS).
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J., Blomström-Lundqvist, C., Boriani, G., Castellá, M., Dan, G., Dilaveris, P. E., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 2,605 · see citing works
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P. F., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castellà, M., Diener, H., Heidbüchel, H., Hendriks, J., et al. (2016) · EP Europace · doi:10.1093/europace/euw295 · Cited by 6,438 · see citing works
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw210 · Cited by 6,418 · see citing works
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Kernan, W. N., Ovbiagele, B., Black, H. R., Bravata, D. M., Chimowitz, M. I., Ezekowitz, M. D., Fang, M. C., Fisher, M., Furie, K. L., Heck, D. V., et al. (2014) · Stroke · doi:10.1161/str.0000000000000024 · Cited by 5,170 · see citing works
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000923 · Cited by 3,686 · see citing works
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.536 · Cited by 3,523 · see citing works
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000031 · Cited by 2,906 · see citing works
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A. M., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001193 · Cited by 2,989 · see citing works
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000932 · Cited by 2,449 · see citing works
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H. M., Krieger, E. V., Mack, M. J., McLeod, C., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.018 · Cited by 2,073 · see citing works
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association Council on Stroke: Co-Sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline.
Sacco, R. L., Adams, R., Albers, G., Alberts, M. J., Benavente, O., Furie, K., Goldstein, L. B., Gorelick, P., Halperin, J., Harbaugh, R., et al. (2006) · Stroke · doi:10.1161/01.str.0000199147.30016.74 · Cited by 1,873 · see citing works
PLACEBO-CONTROLLED, RANDOMISED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL FIBRILLATION
Petersen, P., GODTFREDSEN, J., Boysen, G., Andersen, E. D., & Andersen, B. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91200-2 · Cited by 1,814 · see citing works
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O'Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.02.537 · Cited by 1,642 · see citing works
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
Furie, K. L., Kasner, S. E., Adams, R. J., Albers, G. W., Bush, R. L., Fagan, S. C., Halperin, J. L., Johnston, S. C., Katzan, I. L., Kernan, W. N., et al. (2010) · Stroke · doi:10.1161/str.0b013e3181f7d043 · Cited by 1,492 · see citing works
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Kirchhof, P., Benussi, S., Kotecha, D., Ahlsson, A., Atar, D., Casadei, B., Castella, M., Diener, H.-C., Heidbuchel, H., Hendriks, J., et al. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw313 · Cited by 1,403 · see citing works
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000029 · Cited by 2,566 · see citing works
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H. M., Krieger, E. V., Mack, M. J., McLeod, C., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.035 · Cited by 1,104 · see citing works
2014 AHA/ACC guideline for the management of patients with valvular heart disease
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., Guyton, R. A., O’Gara, P. T., Ruiz, C. E., Skubas, N. J., Sorajja, P., et al. (2014) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2014.05.014 · Cited by 990 · see citing works
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation
Joglar, J. A., Chung, M. K., Armbruster, A. L., Benjamin, E. J., Chyou, J. Y., Cronin, E. M., Deswal, A., Eckhardt, L. L., Goldberger, Z. D., Gopinathannair, R., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.08.017 · Cited by 933 · see citing works
Antithrombotic Therapy in Atrial Fibrillation
Singer, D. E., Albers, G. W., Dalen, J. E., Fang, M. C., Go, A. S., Halperin, J. L., Lip, G. Y. H., & Manning, W. J. (2008) · CHEST Journal · doi:10.1378/chest.08-0678 · Cited by 755 · see citing works
Relation between echocardiographically determined left atrial size and atrial fibrillation.
Henry, W. L., Morganroth, J., Pearlman, A. S., Clark, C. E., Redwood, D. R., Itscoitz, S. B., & Epstein, S. E. (1976) · Circulation · doi:10.1161/01.cir.53.2.273 · Cited by 641 · see citing works
“Of the patients with asymmetric septal hypertrophy who embolized, nine of 11 (82%) at the time of echocardiographic study would have been classified by history as having either chronic (7) or paroxysmal (2) atrial fibrillation.”
Background
Antithrombotic and Thrombolytic Therapy for Valvular Disease
Whitlock, R. P., Sun, J. C. J., Fremes, S. E., Rubens, F. D., & Teoh, K. (2012) · CHEST Journal · doi:10.1378/chest.11-2305 · Cited by 623 · see citing works
Antithrombotic Therapy in Atrial Fibrillation
Singer, D. E., Albers, G. W., Dalen, J. E., Go, A. S., Halperin, J. L., & Manning, W. J. (2004) · CHEST Journal · doi:10.1378/chest.126.3_suppl.429s · Cited by 547 · see citing works
The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation
Bjerkelund, C. J., & Orning, O. M. (1969) · The American Journal of Cardiology · doi:10.1016/0002-9149(69)90068-x · Cited by 447 · see citing works
A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study
Hobbs, F., Fitzmaurice, D., Mant, J., Murray, E., Jowett, S., Bryan, S., Raftery, J., Davies, M., & Lip, G. (2005) · Health Technology Assessment · doi:10.3310/hta9400 · Cited by 437 · see citing works
Antithrombotic Therapy in Valvular Heart Disease—Native and Prosthetic
Salem, D. N., Stein, P. D., Al‐Ahmad, A., Bussey, H. I., Horstkotte, D., Houston-Miller, N., & Pauker, S. G. (2004) · CHEST Journal · doi:10.1378/chest.126.3_suppl.457s · Cited by 374 · see citing works
Parenteral anticoagulants in heart disease: Current status and perspectives (Section II)
Husted, S., Wallentin, L. C., Andreotti, F., Arnesen, H., Bachmann, F., Baigent, C., Huber, K., Jespersen, J., Kristensen, S. D., Lip, G. Y. H., et al. (2013) · Thrombosis and Haemostasis · doi:10.1160/th12-06-0403 · Cited by 366 · see citing works
Vitamin K antagonists in heart disease: Current status and perspectives (Section III)
Husted, S., Wallentin, L. C., Andreotti, F., Arnesen, H., Bachmann, F., Baigent, C., Huber, K., Jespersen, J., Kristensen, S. D., Lip, G. Y. H., et al. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-06-0443 · Cited by 367 · see citing works
“This situation, of which mitral stenosis is the landmark, is thought to carry the greatest risk of systemic thromboembolism of any common form of acquired native valvular disease, even in the absence of AF, although such estimates are based on old literature (159).”
Background
Management of Atrial Fibrillation
Wood, A. J. J., & Pritchett, E. L. C. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205073261906 · Cited by 322 · see citing works
Immediate anticoagulation of embolic stroke: a randomized trial. Cerebral Embolism Study Group.
(1983) · Stroke · doi:10.1161/01.str.14.5.668 · Cited by 300 · see citing works
“A-6 c 60M N V A F 150/100 yes M 32 35 no H (9) —”
Systemic embolism in mitral valve disease.
Coulshed, N., Epstein, E. J., McKendrick, C. S., Galloway, R. W., & Walker, E. (1970) · Heart · doi:10.1136/hrt.32.1.26 · Cited by 301 · see citing works
Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines
Veitch, A., Vanbiervliet, G., Gershlick, A., Boustière, C., Baglin, T. P., Smith, L., Radaelli, F., Knight, E., Gralnek, I. M., Hassan, C., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-311110 · Cited by 301 · see citing works
New Evidence for Stroke Prevention
Straus, S. E., Majumdar, S. R., & McAlister, F. A. (2002) · JAMA · doi:10.1001/jama.288.11.1388 · Cited by 296 · see citing works
“Antiplatelet therapy Aspirin 28 (19-36) 77 (9.”
BackgroundInfluential
2020 ACC/AHA guideline for the management of patients with valvular heart disease
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2021.04.002 · Cited by 279 · see citing works
Antithrombotic Therapy in Atrial Fibrillation
DUNN, M. I., Alexander, J. K., de Silva, R., & Hildner, F. J. (1989) · CHEST Journal · doi:10.1378/chest.95.2_supplement.118s · Cited by 270 · see citing works
Immediate anticoagulation of embolic stroke: brain hemorrhage and management options. Cerebral Embolism Study Group.
(1984) · Stroke · doi:10.1161/01.str.15.5.779 · Cited by 264 · see citing works
Care of Patients Receiving Long-Term Anticoagulant Therapy
Schulman, S. (2003) · New England Journal of Medicine · doi:10.1056/nejmcp025373 · Cited by 242 · see citing works
Influence of etiology of atrial fibrillation on incidence of systemic embolism
Hinton, R. C., Kistler, J. P., Fallon, J. T., Friedlich, A. L., & Fisher, C. M. (1977) · The American Journal of Cardiology · doi:10.1016/0002-9149(77)90064-9 · Cited by 247 · see citing works
Valvular and Structural Heart Disease
Salem, D. N., O’Gara, P. T., Madias, C. A., & Pauker, S. G. (2008) · CHEST Journal · doi:10.1378/chest.08-0724 · Cited by 239 · see citing works
2020 Clinical guidelines for Atrial fibrillation and atrial flutter
Arakelyan, M. S., Bockeria, L. A., Vasilieva, E., Sp, G., Golukhova, E. Z., Gorev, M. V., Davtyan, K. V., Drapkina, O. M., Станиславовна, К. Е., Kuchinskaya, Е. А., et al. (2021) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2021-4594 · Cited by 255 · see citing works
ATRIAL FIBRILLATION
Åberg, H. E. (1969) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1969.tb07351.x · Cited by 226 · see citing works
Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines
Veitch, A., Vanbiervliet, G., Gershlick, A., Boustière, C., Baglin, T. P., Smith, L., Radaelli, F., Knight, E., Gralnek, I. M., Hassan, C., et al. (2016) · Endoscopy · doi:10.1055/s-0042-102652 · Cited by 224 · see citing works
Guidelines for the management of anticoagulant and antiplatelet therapy in patients undergoing endoscopic procedures
Veitch, A., Baglin, T. P., Gershlick, A., Harnden, S. M., Tighe, R., & Cairns, S. R. (2008) · Gut · doi:10.1136/gut.2007.142497 · Cited by 214 · see citing works
Nonrheumatic atrial fibrillation. Risk of stroke and role of antithrombotic therapy.
Cairns, J., & Connolly, S. J. (1991) · Circulation · doi:10.1161/01.cir.84.2.469 · Cited by 207 · see citing works
Risk for systemic embolization of atrial fibrillation without mitral stenosis
Cabin, H. S., Clubb, K. S., Hall, C., Perlmutter, R. A., & Feinstein, A. R. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)90323-s · Cited by 199 · see citing works
Antithrombotic Therapy in Valvular Heart Disease
Salem, D. N., Levine, H. J., Pauker, S. G., Eckman, M. H., & Daudelin, D. H. (1998) · CHEST Journal · doi:10.1378/chest.114.5_supplement.590s · Cited by 194 · see citing works
Thromboembolic complications in atrial fibrillation.
Petersen, P. (1990) · Stroke · doi:10.1161/01.str.21.1.4 · Cited by 193 · see citing works
Cardiac thrombosis and thromboembolism in chronic chagas' heart disease
de Oliveira, J. S. M., de Araújo, R. C., Navarro, M. A., & Muccillo, G. (1983) · The American Journal of Cardiology · doi:10.1016/0002-9149(83)90085-1 · Cited by 178 · see citing works
Antithrombotic Therapy in Atrial Fibrillation
Laupacis, A., Albers, G. W., DUNN, M. I., & Feinberg, W. M. (1992) · CHEST Journal · doi:10.1378/chest.102.4_supplement.426s · Cited by 169 · see citing works
Usefulness of anticoagulant therapy in the prevention of embolic complications of atrial fibrillation
Roy, D., Marchand, E., Gagné, P., Chabot, M., & Cartier, R. (1986) · American Heart Journal · doi:10.1016/0002-8703(86)90318-2 · Cited by 166 · see citing works
Management of cerebral embolism of cardiac origin.
Easton, J. D., & Sherman, D. G. (1980) · Stroke · doi:10.1161/01.str.11.5.433 · Cited by 161 · see citing works
Pharmacotherapeutic Aspects of Unfractionated and Low Molecular Weight Heparins
Verstraete, M. (1990) · Drugs · doi:10.2165/00003495-199040040-00003 · Cited by 147 · see citing works
Risk of recurrent stroke in patients with atrial fibrillation and non-valvular heart disease.
Sage, J. I., & Uitert, R. L. V. (1983) · Stroke · doi:10.1161/01.str.14.4.537 · Cited by 147 · see citing works
Mitral valve disease, systemic embolism and anticoagulants
Fleming, H. A., & Bailey, S. M. (1971) · Postgraduate Medical Journal · doi:10.1136/pgmj.47.551.599 · Cited by 146 · see citing works
XIV. Cerebral ischemia: the role of thrombosis and of antithrombotic therapy. Study group on antithrombotic therapy.
Genton, E., Barnett, H. J. M., Fields, W. S., Gent, M., & Hoak, J. C. (1977) · Stroke · doi:10.1161/01.str.8.1.150 · Cited by 140 · see citing works
Arterial Embolism in Thyrotoxicosis With Atrial Fibrillation
Bar-Sela, S. (1981) · Archives of Internal Medicine · doi:10.1001/archinte.1981.00340090087019 · Cited by 138 · see citing works
Ischemic Cerebrovascular Complications of Pregnancy
Wiebers, D. O. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100092030 · Cited by 135 · see citing works
Cerebral infarction in young adults.
Grindal, A. B., Cohen, R. J., Saul, R. F., & Taylor, J. R. (1978) · Stroke · doi:10.1161/01.str.9.1.39 · Cited by 133 · see citing works
“The search for a cardiac embolic source is important since the value of anticoagulation in decreasing mortality and preventing recurrent embolism has been established.(14)'(16)”
Background
Antithrombotic treatment in atrial fibrillation
Lip, G. Y. H., & Boos, C. J. (2005) · Postgraduate Medical Journal · doi:10.1136/hrt.2005.066944 · Cited by 124 · see citing works
Cerebral embolism and mitral stenosis: survival with and without anticoagulants
Adams, G., Merrett, J. D., Hutchinson, W. M., & Pollock, A. M. (1974) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.37.4.378 · Cited by 122 · see citing works
“…of 172 patients reviewed by Keen and Leveaux (1958) showed an incidence of cerebral embolism of 20% but, in a much larger series (754 patients), Szekely (1964) found the overall incidence to be 9.6%0 onethird of emboli occurring within one month and two-thirds within a year of the onset of…”
BackgroundInfluential
Ten to fifteen year reassessment of the performance characteristics of the Starr-Edwards Model 6120 mitral valve prosthesis
Miller, D. C., Oyer, P. E., Stinson, E. B., Reitz, B. A., Jamieson, S. W., Baumgartner, W. A., Mitchell, R. S., & Shumway, N. E. (1983) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)38894-4 · Cited by 121 · see citing works
Clinical and neuroradiological analysis of thrombotic and embolic cerebral infarction.
Yamaguchi, T., Minematsu, K., Choki, J.-I., & Ikeda, M. (1984) · Japanese Circulation Journal-english Edition · doi:10.1253/jcj.48.50 · Cited by 118 · see citing works
Perindopril-Based Blood Pressure–Lowering Reduces Major Vascular Events in Patients With Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack
Arima, H., Hart, R. G., Colman, S., Chalmers, J. P., Anderson, C. S., Rodgers, A., Woodward, M., MacMahon, S. W., & Neal, B. C. (2005) · Stroke · doi:10.1161/01.str.0000181115.59173.42 · Cited by 109 · see citing works
Antithrombotic therapy in patients with valvular heart disease and prosthetic heart valves
Chesebro, J. H., Adams, P. C., & Fuster, V. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80006-7 · Cited by 107 · see citing works
PROGNOSIS OF CEREBRAL EMBOLISM
Carter, A. B. (1965) · The Lancet · doi:10.1016/s0140-6736(65)91473-x · Cited by 105 · see citing works
Coagulation activity is increased in the left atrium of patients with mitral stenosis
Yamamoto, K., Ikeda, U., Seino, Y., Mito, H., Fujikawa, H., Sekiguchi, H., & Shimada, K. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)00322-h · Cited by 102 · see citing works
Modern Management of Prosthetic Valve Anticoagulation
Tiede, D. J., Nishimura, R. A., Gastineau, D. A., Mullany, C. J., Orszulak, T. A., & Schaff, H. V. (1998) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)64893-3 · Cited by 96 · see citing works
Cardiac valve prostheses in children without anticoagulation
Pass, H. I., Sade, R. M., Crawford, F. A., & Hohn, A. R. (1984) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)38409-0 · Cited by 87 · see citing works
Preventive health care, 1999 update: 2. Echocardiography for the detection of a cardiac source of embolus in patients with stroke. Canadian Task Force on Preventive Health Care.
Kapral, M. K., & Silver, F. L. (1999) · PubMed · Cited by 87 · see citing works
Long-term results of DC reversion of atrial fibrillation.
Radford, M. D., & Evans, D. W. (1968) · Heart · doi:10.1136/hrt.30.1.91 · Cited by 87 · see citing works
“In patients with rheumatic heart disease the risk of embolism, while greater in those with atrial fibrillation (Szekely, 1964), is presumably decreased only”
Background
Physician Variation in Anticoagulating Patients With Atrial Fibrillation
Chang, H. J. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.1990.00390130089012 · Cited by 86 · see citing works
Determinants of Increased Regional Left Atrial Coagulation Activity in Patients With Mitral Stenosis
Peverill, R. E., Harper, R. W., Gelman, J. S., Gan, T. E., Harris, G., & Smolich, J. J. (1996) · Circulation · doi:10.1161/01.cir.94.3.331 · Cited by 82 · see citing works
Incidence of systemic embolism before and after mitral valvotomy
Deverall, P. B., Olley, P. M., Smith, D. R., WATSON, D. A., & Whitaker, W. (1968) · Thorax · doi:10.1136/thx.23.5.530 · Cited by 82 · see citing works
“It is notable in Table VII that the duration of pre-operative study varied from four years (Ban-nister, 1960) to 20 years (Szekely, 1964).”
BackgroundResultInfluential
Predictors of left atrial spontaneous echo contrast and thrombi in patients with mitral stenosis and atrial fibrillation
González‐Torrecilla, E., Fernández, M. Á. G., David, E. P., Bermejo, J., Moreno, M., & Delcán, J. L. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01007-9 · Cited by 80 · see citing works
Treatment of progressing stroke.
Millikan, C. H., & MCDOWELL, F. H. (1981) · Stroke · doi:10.1161/01.str.12.4.397 · Cited by 78 · see citing works
DIRECT CURRENT COUNTERSHOCK COMPLICATIONS
Åberg, H. E., & Cullhed, I. (1968) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1968.tb10501.x · Cited by 75 · see citing works
Anticoagulant-related hemorrhage in acute cerebral embolism.
Shields, R. W., Laureno, R., Lachman, T., & Victor, M. (1984) · Stroke · doi:10.1161/01.str.15.3.426 · Cited by 74 · see citing works
Predictors of Cerebrovascular Events and Death Among Patients With Valvular Heart Disease
Petty, G. W., Khandheria, B. K., Whisnant, J. P., Sicks, J. D., O’Fallon, W. M., & Wiebers, D. O. (2000) · Stroke · doi:10.1161/01.str.31.11.2628 · Cited by 73 · see citing works
Mitral Valve Replacement with the Hancock Bioprosthesis: Five- to Ten-Year Follow-up
Borkon, A. M., McIntosh, C. L., Rueden, T. J. V., & Morrow, A. G. (1981) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(10)61019-3 · Cited by 73 · see citing works
Thromboembolic complications after mitral valve replacement with Hancock xenograft
Hetzer, R., Hill, J. D., Kerth, W. J., Ansbro, J. F., Adappa, M. G., Rodvien, R., Kamm, B., & Gerbode, F. L. A. (1978) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)41309-3 · Cited by 69 · see citing works
Making Decisions About Antithrombotic Therapy in Heart Disease: Decision Analytic and Costeffectiveness Issues
Eckman, M. H., Levine, H. J., Salem, D. N., & Pauker, S. G. (1998) · CHEST Journal · doi:10.1378/chest.114.5_supplement.699s · Cited by 68 · see citing works
Haemorrhagic and thromboembolic complications in patients with atrial fibrillation on anticoagulant prophylaxis
Lundström, T., & Rydén, L. (1989) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1989.tb00053.x · Cited by 63 · see citing works
New Evidence for Stroke Prevention
Straus, S. E., Majumdar, S. R., & McAlister, F. A. (2002) · Cited by 61 · see citing works
Nonvalvular atrial fibrillation as a cause of fatal massive cerebral infarction in the elderly.
Yamanouchi, H., Tomonaga, M., Shimada, H., Matsushita, S., Kuramoto, K., & TOYOKURA, Y. (1989) · Stroke · doi:10.1161/01.str.20.12.1653 · Cited by 61 · see citing works
Effectiveness of systematic screening for the detection of atrial fibrillation
Moran, P. S., Flattery, M. J., Teljeur, C., Ryan, M., & Smith, S. M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009586.pub2 · Cited by 61 · see citing works
Antithrombotic Therapy in Valvular Heart Disease
Salem, D. N., Hartnett Daudelin, D., Levine, H. J., Pauker, S. G., Eckman, M. H., & Riff, J. (2001) · Chest · doi:10.1378/chest.119.1_suppl.207s · Cited by 60 · see citing works
The INVICTUS rheumatic heart disease research program: Rationale, design and baseline characteristics of a randomized trial of rivaroxaban compared to vitamin K antagonists in rheumatic valvular disease and atrial fibrillation
Karthikeyan, G., Connolly, S. J., Ntsekhe, M., Benz, A. P., Rangarajan, S., Lewis, G., Yun, Y., Sharma, S. K., Maklady, F., Elghamrawy, A., et al. (2020) · American Heart Journal · doi:10.1016/j.ahj.2020.03.018 · Cited by 58 · see citing works
Open mitral valvotomy
Smith, W., Neutze, J. M., Barratt‐Boyes, B. G., Lowe, J. B., Upsdell, M. P., & Pemberton, J. R. (1981) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)39271-2 · Cited by 58 · see citing works
Indexes of hypercoagulability measured in peripheral blood reflect levels in intracardiac blood in patients with atrial fibrillation secondary to mitral stenosis
Li‐Saw‐Hee, F. L., Blann, A. D., Goldsmith, I. R. A., & Lip, G. Y. H. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00060-0 · Cited by 57 · see citing works
Relation Between Mitral Regurgitation and Platelet Activation
Tse, H., Lau, C., & Cheng, G. Y.-M. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00380-x · Cited by 56 · see citing works
The risk of thromboembolism and hemorrhage following mitral valve replacement
González-Lavin, L., Tandon, A. P., Chi, S., Blair, T. C., McFadden, P. M., Lewis, B., Daughters, G. T., & Ionescu, M. I. (1984) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)37383-0 · Cited by 55 · see citing works
Embolic complications of porcine heterograft cardiac valves
Jamieson, W. R. E., Janusz, M. T., Miyagishima, R. T., Munro, A. I., Tutassura, H., Gerein, A. N., Burr, L. H., & Allen, P. (1981) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)39498-x · Cited by 55 · see citing works
Influence of mitral regurgitation on left atrial thrombus and spontaneous echocardiographic contrast in patients with rheumatic mitral valve disease
Karatasakis, G., Gotsis, A., & Cokkinos, D. V. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80081-2 · Cited by 54 · see citing works
Diretrizes Brasileiras de Antiagregantes Plaquetários e Anticoagulantes em Cardiologia
Filho, A. M. L., Azmus, A., Soeiro, A., Quadros, A., Avezum, Á., Marques, A., Franci, A., Manica, A., Volschan, A., de Paola, A., et al. (2013) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.2013s009 · Cited by 55 · see citing works
Systemic Embolism in Mitral Stenosis: Relation to the Size of the Left Atrial Appendix
Somerville, W., & Chambers, R. J. (1964) · BMJ · doi:10.1136/bmj.2.5418.1167 · Cited by 53 · see citing works
Effect of antithrombotic therapy in patients with mitral stenosis and atrial fibrillation: a sub-analysis of NASPEAF randomized trial
Pérez-Gómez, F., Salvador, A., Zumalde, J., Iriarte, J. A., Berjón, J., Alegría, E., Almerı́a, C., Bover, R., Herrera, D., & Fernández, C. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi667 · Cited by 50 · see citing works
“Total embolism and haemorrhagic strokes (rate) 10 (4.81) 6 (2.92) 4 (1.43) 2 (0.78) 6 (5.77) 4 (3.46) Death from heart failure 1 0 1 0 0 0 Severe bleeding (fatal) 5 (3) 5 (2) 3 (0) 4 (0) 5 (2) 3 ( 1 )”
Influential
Anticoagulation and Hemorrhagic Infarction in Cerebral Embolism Secondary to Rheumatic Heart Disease
Calandre, L., Ortega, J. F., & Bermejo, F. (1984) · Archives of Neurology · doi:10.1001/archneur.1984.04050220046013 · Cited by 49 · see citing works
The 2014 Atrial Fibrillation Guidelines Companion: A Practical Approach to the Use of the Canadian Cardiovascular Society Guidelines
Macle, L., Cairns, J. A., Andrade, J. G., Mitchell, L. B., Nattel, S., Verma, A., Verma, A., Macle, L., Andrade, J. G., Atzema, C. L., et al. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.06.005 · Cited by 47 · see citing works
Warfarin for Dilated Cardiomyopathy
Tsevat, J., Eckman, M. H., Mcnutt, R., & Pauker, S. G. (1989) · Medical Decision Making · doi:10.1177/0272989x8900900303 · Cited by 47 · see citing works
Atrial fibrillation: mechanism and clinical management
Hu, Z., Ding, L., & Yao, Y. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002906 · Cited by 45 · see citing works
“[43] Patients taking warfarin should undergo regular monitoring of the international normalized ratio (INR) and adjust the dosage to maintain it within the therapeutic target range of 2.0 to 3.0.”
Influential

Authors: Szekely, P.
Corresponding author: Szekely, P.
Venue: BMJ
Publisher: BMJ
Published: 1964-05-09
Volume: 1
Issue: 5392
Pages: 1209-1212
ISSN: 0007-1447 (ISSN-L)
0959-8138
1468-5833
DOI: 10.1136/bmj.1.5392.1209
PMC: PMC1814317
OpenAlex: W2089419646
Cited by: 325
References: 27
Citations by year: 2026: 1 · 2025: 1 · 2023: 5 · 2022: 1 · 2021: 7 · 2020: 9 · 2019: 3 · 2018: 6 · 2017: 5 · 2016: 7 · 2015: 6 · 2014: 10 · 2013: 10 · 2012: 5
FWCI: 9.44
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: BMJ (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Streptococcal Infections and Treatments
Health Sciences › Medicine › Epidemiology › Infective Endocarditis Diagnosis and Management
Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
Keywords: systemic embolism, thromboprophylaxis, rheumatic heart disease, thromboembolism, valvular heart disease
MeSH terms: Anticoagulants, Atrial Fibrillation, Embolism, Cardiac Surgical Procedures, Humans, Mitral Valve Stenosis, Preventive Medicine, Rheumatic Heart Disease, Statistics as Topic, Thoracic Surgery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Systemic Embolism and Anticoagulant Prophylaxis in Rheumatic Heart Disease

Integrity signals

Claims the paper makes

Claims other papers make about this one

Self-check

Cites

Cited by

Related

Record

About these checks